関連する実験動画
Updated: Jan 9, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
ヒト染色体22の第1世代結合不均衡マップである
Elisabeth Dawson1, Gonçalo R Abecasis, Suzannah Bumpstead
1The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
Nature
|July 12, 2002
まとめ
研究者らは,ヒト染色体22の結合不均衡 (LD) をマッピングした. 彼らは高度に変動するLDパターンを発見し,長期にわたる強い関連が低関連領域と交差し,LDマッピングの可行性を確認しました.
科学分野:
- 人間の遺伝学 人間の遺伝学
- ゲノム変異によるゲノム変異
- 人口遺伝学 人口遺伝学
背景:
- DNA配列の変異は,疾患のリスクや薬物反応などの現象型に影響します.
- 結合不均衡 (LD) は,変種と隣接するマーカー間の非ランダムな関連を記述する.
- LDパターンの理解は,遺伝学研究と全ゲノム関連研究において極めて重要です.
研究 の 目的:
- 人間の全染色体22の結合不均衡 (LD) を測定し,特徴づけること.
- LDパターンと再結合率との関係を調査する.
- ゲノム全体にわたるLDマップの作成の実現可能性を実証する.
主な方法:
- ヒトポリモルフィズム研究センター (CEPH) のリファレンスファミリーにおける染色体22の1,504のマーカーのゲノタイプ化.
- 15キロベース (kb) のメディアンマーカー間隔でLDパターンの分析.
- 関連性のないイギリス系白人のパネルにおけるLDパターン分析の複製.
主要な成果:
- 染色体22に沿って,高度に変動するLDパターンが観察され,高いLDの広範囲の領域 (最大804kb) とLDの低い/ない領域が観察されました.
- LDのパターンは,CEPHファミリーと無縁の英国白人との間で一貫していました.
- 高いLDと低い再結合頻度との間に強い相関が認められ,安定した再結合率を示唆した.
結論:
- この研究では,完全なヒト染色体全体でLDを測定し,複雑なパターンを明らかにしました.
- この発見は,包括的な全ゲノムにわたるLDマップの開発の実現可能性を裏付けています.
- LDマッピングは,遺伝子研究と人間の多様性を理解するための実行可能な戦略です.
関連する概念動画
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K